| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allovir, Inc. | Director | Common Stock | 3.16M | $2.12M | $0.67 | May 25, 2021 | Indirect |
| Allovir, Inc. | Director | Stock Option (Right to Buy) | 22.5K | May 25, 2021 | Direct | ||
| Marker Therapeutics, Inc. | Director | Stock Option (right to buy) | 8K | Jun 6, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| MRKR | Marker Therapeutics, Inc. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| MRKR | Marker Therapeutics, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| ALVR | Allovir, Inc. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |